Paradigm Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Paradigm Capital Management Inc's BMY Position: Q1 2026 in Review
Paradigm Capital Management Inc held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,100 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #108.
Paradigm Capital Management Inc first reported a position in BMY in Q3 2019 and has held it in 27 quarters since. The position peaked at $785K in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Paradigm Capital Management Inc held 5,100 shares of Bristol-Myers Squibb worth $309K as of Q1 2026.
- Paradigm Capital Management Inc left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of Paradigm Capital Management Inc's portfolio in Q1 2026, its #108 holding.
- Paradigm Capital Management Inc first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 27 quarters since.
- Paradigm Capital Management Inc's Bristol-Myers Squibb position peaked at $785K in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Paradigm Capital Management Inc's 13F filing for Q1 2026, filed 14 May 2026.